Taiwan, one of the countries in Asia, has been recently hit by yet another outbreak of Coronavirus – called “Cavesticella Zoster Virus (VLTV). The latest outbreak is also attributed to the reuse of contaminated clothes by infected patients. The latest outbreak was confirmed on the island of Taiwan. The first outbreak of Coronavirus in Taiwan took place on November 11, 2021. There have been no new deaths or reported illnesses so far. However, the laboratories in Taiwan have been conducting diagnostic testing and clinical research on this outbreak since then.
On December 13, the laboratory of the Ministry of Health received a sample from a person who had symptoms of Coronavirus infection but no other disease. A culture was done from the sample and the virus identification and analysis work on the sample was done by the microbiology department of the University of Taipei. The examination of the sample showed that the sample had a high level of genetic material which is characteristic of viral infection. The corresponding viral agent is now being studied in laboratories around the world. The laboratory is still continuing with the analysis and testing of the sample.
The Taiwan chip maker has released an update on its website on December 14th. The update says, Coronavirus – which has been named Coronavirus: Taiwan, is associated with the infection of the Leptospirosis bacteria. Based on the Taiwan clinic’s investigation, the latest outbreak of Coronavirus in Taiwan was caused by two different strains – one that caused a mild infection and one that caused a more severe infection. Based on the laboratory analysis, the laboratory found a connection between this strain and the second outbreak of Coronavirus in Taiwan.
According to the Taiwan laboratory, the latest strain of Coronavirus is proving to be resistant to the previously existing strains of the virus. Based on this information, there are high chances that the new variant of the virus may cause more serious problems in the future. Hence, the laboratory is conducting further tests to confirm the association between this strain and other diseases. There have been rumors that the Taiwan chipmaker may restrict the selling of recalled products due to the new outbreak of Coronavirus in Taiwan. If the company confirms the first outbreak of the virus in Taiwan, then they will definitely do everything possible to stop the second outbreak.
The laboratory has confirmed the connection between this strain of Coronavirus and L. canicola, a strain that causes the common infection called Lassa fever. This bacterium is believed to have spread to several other countries especially to those places where there is poor hygiene. Because L. canicola is the causative agent of this disease, the Taiwanese chipmaker is taking the necessary steps to contain its production. As of the moment, the maximum number of infections caused by this virus is still continuing to rise, with some cases of severe infections having been reported as of the moment of writing this article.
One of the most important aspects of this case study is that, unlike the first outbreak of Coronavirus in Taiwan, this time the laboratory has confirmed the infection with this newest variant of the virus. This confirms that L. canicola is now considered a high-risk pathogen for infection with this pathogen. Considering that the Taiwan laboratory confirmed the presence of this new variant of this pathogen, there is a great possibility that other patients of Lassa fever may also be infected with this virus. Hence, the number of patients diagnosed with Lassa fever is expected to increase once this new variant of the disease is released into the market.
The laboratory also confirmed the diagnosis of the patients with this new variant of the disease by performing polymerase chain reaction (PCR) tests. Polymerase chain reaction (PCR) tests enable healthcare experts and other medical professionals to detect and confirm the presence of virus infection in living persons. Through this, the laboratory technicians of the Taiwan chipmaker have been able to confirm the second outbreak of Coronavirus in Taiwan.
To conclude, the Taiwan hospital has confirmed the existence of Lassa fever in human beings. The laboratory has also confirmed the infection with this new variant of the Coronavirus. Because of this, the number of patients infected with this pathogen is expected to increase once this virus is released into the market. Although no deaths have been reported so far, the probability of infection to those who are immune-compromised is very high. That is why all infected people should be monitored closely at every stage of treatment.
